We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editor's Correspondence |

Routine Booster Doses of Hepatitis B Vaccine for Health Care Workers Are Not Necessary—Reply

Craig Barash, MD; Mitchell I. Conn, MD; Anthony J. DiMarino Jr, MD; Joseph Marzano, MD; Melvin L. Allen, PhD
Arch Intern Med. 2000;160(20):3171. doi:.
Text Size: A A A
Published online


In reply

We appreciate the interest and comments from Dr Datta and colleagues regarding our article titled "Serologic Hepatitis B Immunity in Vaccinated Health Care Workers." We agree that immune responsiveness to hepatitis B should be documented 1 to 2 months after completion of the vaccination protocol. However, our study showed that postvaccination testing is not routinely practiced. We found that only 40% of HCWs had their titers checked after vaccination. Twenty-nine percent (45/154) of the HCWs whom we tested did not have detectable hepatitis B antibody levels 4.7 years after vaccination. The majority of these subjects (33/45) never underwent postvaccination testing 1 to 2 months after receiving vaccine, and only 16% (7/45) had documented immunity. This leaves a large group (38/45) whose response to vaccination is unknown. Although large proportions of these subjects probably have anamnestic potential, we cannot distinguish them from nonresponders. We believe that it would be prudent to give this group a booster dose of vaccine to identify true nonresponders from anamnestic responders, because these groups will need to be treated differently in the event of exposure. The true nonresponders would require hepatitis B immune globulin alone, whereas the anamnestic responders without detectable antibody would need only a vaccine booster. If we follow the recommendations of Dr Datta and coworkers, an inordinate number of subjects may unnecessarily receive hepatitis B immune globulin, with the associated increased costs. We agree with Dr Datta and colleagues that this dilemma can be avoided if postvaccination antibody testing is performed 1 to 2 months after vaccination. If the initial response to postvaccination testing is positive, then we agree that periodic testing and booster vaccination are not necessary. In the absence of a positive titer antibody after vaccination, HCWs should consider undergoing a booster hepatitis B vaccination.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
Infection Control Q-and-A. J Calif Dent Assoc 2016;44(2):135-6, 138.
[Not Available]. Rev Med Suisse 2016;12(511):622-3.